Stay updated with breaking news from Pharma india. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS).
This is the last trading week for the stock market this year. So will the year end on a happy note? Check out what the day can have in store, , stock market today, gold prices, silver prices, nse nifty, bse sensex
BSE's Sensex jumped 241.86 points, or 0.34 per cent, to settle at 71,106.96. NSE's Nifty50 gained 76.25 points, or 0.36 per cent, to end the day at 21,331.30 for the day.
The company will position the manufacturing site for sale in a fully operational manner and begin a search for a buyer who can also act as a contract manufacturing organisation (CMO) for its products currently manufactured or packaged at the site, subject to receipt of necessary statutory approvals, the drug firm said.
One of the major brains behind numerous evidence-based Dental Implantology Dr Frank Schwarz, professor and chairman of the Department of Oral Surgery and Implantology at the Centre for Dentistry and Oral Medicine (Carolinum) at the Johann Wolfgang Goethe-University in Frankfurt, Germany, is in Nepal teaching implantology to 50 dentists from Nepal and India.
Artificial intelligence (AI) can uncover new insights and enhance the effectiveness of product sales by analyzing vast amounts of healthcare data. However, the adoption of AI in medical sales and healthcare professionals in India still has room for improvement, with only a small fraction of companies advanced in AI implementation. AI can empower sales representatives by providing valuable recommendations and handling customization of interactions with healthcare professionals.
AstraZeneca Pharma India on Monday said it has received approval from the Drugs Controller General of India to import heart failure treatment drug Dapagliflozin tablets. The company has received permission from the DCGI to import pharmaceutical formulations of a new drug for sale, the drug firm said in a regulatory filing.
India's pharma sector on Wednesday said the Goods and Services Tax (GST) Council's decision to exempt tax on rare diseases drugs is unlikely to benefit the population unless the waiver is extended to drugs that are made commercially available in the country.
The GST Council on Tuesday (July 11) said the Integrated Goods and Services Tax (IGST) on medicines and Food for Special Medical Purposes (FSMP) used for treating rare diseases enlisted under the National Policy for Rare Diseases, 2021, will be exempt when imported for personal use subject to existing conditions.
'We support the government's move to address the needs of patients suffering from rare diseases.